Related references
Note: Only part of the references are listed.Targeted Protein Degradation Induced by HEMTACs Based on HSP90
Zhenzhen Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Targeted degradation via direct 26S proteasome recruitment
Charlene Bashore et al.
NATURE CHEMICAL BIOLOGY (2023)
Discovery of LL-K8-22: A Selective, Durable, and Small-Molecule Degrader of the CDK8-Cyclin C Complex
Mingyu Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Targeting androgen receptor degradation with PROTACs from bench to bedside
Xiaojuan Jia et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
Progress of small molecules for targeted protein degradation: PROTACs and other technologies
Hong-Yi Zhao et al.
DRUG DEVELOPMENT RESEARCH (2023)
Order through destruction: how ER-associated protein degradation contributes to organelle homeostasis
John C. Christianson et al.
EMBO JOURNAL (2022)
Efficient targeted oncogenic KRASG12C degradation via first reversible-covalent PROTAC
Fang Yang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design and synthesis of marine sesterterpene analogues as novel estrogen receptor a degraders for breast cancer treatment
Jian-Jia Liang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
PROTAC cell permeability and oral bioavailability: a journey into uncharted territory
Vasanthanathan Poongavanam et al.
FUTURE MEDICINAL CHEMISTRY (2022)
PROTAC targeted protein degraders: the past is prologue
Miklos Bekes et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Hydrophobic Tagging-Induced Degradation of PDEδ in Colon Cancer Cells
Menglu Guo et al.
ACS MEDICINAL CHEMISTRY LETTERS (2022)
Conversion of a PROTAC Mutant Huntingtin Degrader into Small-Molecule Hydrophobic Tags Focusing on Drug-like Properties
Keigo Hirai et al.
ACS MEDICINAL CHEMISTRY LETTERS (2022)
Challenges and opportunities for in vivo PROTAC delivery
Andrew B. Benowitz et al.
FUTURE MEDICINAL CHEMISTRY (2022)
Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond
Yue Zhong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer
Jiahao Qiu et al.
FRONTIERS IN PHARMACOLOGY (2022)
Phase 1b study of bavdegalutamide, an androgen receptor PROTACdegrader, combined with abiraterone in patients with metastatic prostate cancer.
Neal D. Shore et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Discovery of Small-Molecule Degraders of the CDK9-Cyclin T1 Complex for Targeting Transcriptional Addiction in Prostate Cancer
Jiacheng Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron
Saki Ichikawa et al.
NATURE (2022)
PROTACs: past, present and future
Ke Li et al.
CHEMICAL SOCIETY REVIEWS (2022)
Carborane as an Alternative Efficient Hydrophobic Tag for Protein Degradation
Yasunobu Asawa et al.
BIOCONJUGATE CHEMISTRY (2021)
Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
Shenxin Zeng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Specific non-genetic IAP-based protein erasers (SNIPERs) as a potential therapeutic strategy
Zonghui Ma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Cancer Selective Target Degradation by Folate-Caged PROTACs
Jing Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Induction of Apoptosis in Cancer Cells by Glutathione Transferase Inhibitor Mediated Hydrophobic Tagging Molecules
Xiaona Li et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
The rise and rise of protein degradation: Opportunities and challenges ahead
Scott J. Hughes et al.
DRUG DISCOVERY TODAY (2021)
Protein degradation technology: a strategic paradigm shift in drug discovery
Haobin Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK)
Shaowen Xie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery
Guoqiang Dong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Unraveling the Role of Linker Design in Proteolysis Targeting Chimeras
Troy A. Bemis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Targeted degradation of transcription factors by TRAFTACs: TRAnscription Factor TArgeting Chimeras
Kusal T. G. Samarasinghe et al.
CELL CHEMICAL BIOLOGY (2021)
Advancing targeted protein degradation for cancer therapy
Brandon Dale et al.
NATURE REVIEWS CANCER (2021)
Degradation of proteins by PROTACs and other strategies
Yang Wang et al.
ACTA PHARMACEUTICA SINICA B (2020)
ATTEC: a potential new approach to target proteinopathies
Zhaoyang Li et al.
AUTOPHAGY (2020)
X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance
Jessica L. Thomaston et al.
BIOCHEMISTRY (2020)
Discovery of a first-in-class EZH2 selective degrader
Anqi Ma et al.
NATURE CHEMICAL BIOLOGY (2020)
Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma
Yetirajam Rajesh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Xin Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Exploiting the folate receptor α in oncology
Mariana Scaranti et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Targeted Degradation of Transcription Coactivator SRC-1 through the N-Degron Pathway
Yeongju Lee et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Put a cork in it: Plugging the M2 viral ion channel to sink influenza
Pouria H. Jalily et al.
ANTIVIRAL RESEARCH (2020)
Discovery of Novel PDEd Degraders for the Treatment of KRAS Mutant Colorectal Cancer
Junfei Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Lysosome-targeting chimaeras for degradation of extracellular proteins
Steven M. Banik et al.
NATURE (2020)
Augmentation of the antitumor effects of PARP inhibitors in triple-negative breast cancer via degradation by hydrophobic tagging modulation
Ahra Go et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry
Wen-Hao Guo et al.
NATURE COMMUNICATIONS (2020)
Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety
Takuji Shoda et al.
PHARMACEUTICALS (2020)
TDP-43 specific reduction induced by Di-hydrophobic tags conjugated peptides
Na Gao et al.
BIOORGANIC CHEMISTRY (2019)
ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer.
Taavi Neklesa et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A Practical Review of Proteasome Pharmacology
Tiffany A. Thibaudeau et al.
PHARMACOLOGICAL REVIEWS (2019)
Recent Progress in TRPM8 Modulation: An Update
Rosario Gonzalez-Muniz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A glycine-specific N-degron pathway mediates the quality control of protein N-myristoylation
Richard T. Timms et al.
SCIENCE (2019)
Development of targeted protein degradation therapeutics
Philip P. Chamberlain et al.
NATURE CHEMICAL BIOLOGY (2019)
An efficient auxin-inducible degron system with low basal degradation in human cells
Shiqian Li et al.
NATURE METHODS (2019)
Sesterterpene MHO7 suppresses breast cancer cells as a novel estrogen receptor degrader
Yue Zhao et al.
PHARMACOLOGICAL RESEARCH (2019)
Development of Small Molecule Chimeras That Recruit AhR E3 Ligase to Target Proteins
Nobumichi Ohoka et al.
ACS CHEMICAL BIOLOGY (2019)
Cellular quality control by the ubiquitin-proteasome system and autophagy
Christian Pohl et al.
SCIENCE (2019)
AUTACs: Cargo-Specific Degraders Using Selective Autophagy
Daiki Takahashi et al.
MOLECULAR CELL (2019)
A MedChem toolbox for cereblon-directed PROTACs
Christian Steinebach et al.
MEDCHEMCOMM (2019)
Latest Overview of the Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: The Past, the Present and the Future
Xiu Chen et al.
JOURNAL OF CANCER (2019)
Poloxin-2HT+: changing the hydrophobic tag of Poloxin-2HT increases Plk1 degradation and apoptosis induction in tumor cells
Stefan Rubner et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2019)
ARV-471, an oral estrogen receptor PROTAC degrader for breast cancer
J. J. Flanagan et al.
CANCER RESEARCH (2019)
The hydrophobically-tagged MDM2-p53 interaction inhibitor Nutlin-3a-HT is more potent against tumor cells than Nutlin-3a
Florian Nietzold et al.
CHEMICAL COMMUNICATIONS (2019)
Development of Safe Drugs: The hERG Challenge
Subha Kalyaanamoorthy et al.
MEDICINAL RESEARCH REVIEWS (2018)
Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor degradation
Nobumichi Ohoka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression
Chong Qin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The Unfolded Protein Response and Cell Fate Control
Claudio Hetz et al.
MOLECULAR CELL (2018)
The dTAG system for immediate and target-specific protein degradation
Behnam Nabet et al.
NATURE CHEMICAL BIOLOGY (2018)
Plasticity in binding confers selectivity in ligand-induced protein degradation
Radoslaw P. Nowak et al.
NATURE CHEMICAL BIOLOGY (2018)
Norbornene in Organic Synthesis
Caifeng Li et al.
SYNTHESIS-STUTTGART (2018)
Acute and rapid degradation of endogenous proteins by Trim-Away
Dean Clift et al.
NATURE PROTOCOLS (2018)
Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
Sainan An et al.
EBIOMEDICINE (2018)
Selective Degradation of Polo-like Kinase 1 by a Hydrophobically Tagged Inhibitor of the Polo-Box Domain
Stefan Rubner et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Crosstalk Between Mammalian Autophagy and the Ubiquitin-Proteasome System
Nur Mehpare Kocaturk et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Novel TRPM8 agonist cooling compound against chronic itch: results from a randomized, double-blind, controlled, pilot study in dry skin
S. Staender et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Induced protein degradation: an emerging drug discovery paradigm
Ashton C. Lai et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Matthew P. Goetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Targeted Inhibition of the NCOA1/STAT6 Protein-Protein Interaction
Yeongju Lee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer
Solange Peters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Targeted protein degradation by PROTACs
Taavi K. Neklesa et al.
PHARMACOLOGY & THERAPEUTICS (2017)
The Ubiquitin Code in the Ubiquitin-Proteasome System and Autophagy
Yong Tae Kwon et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Hydrophobic tagging-mediated degradation of Alzheimer's disease related Tau
Na Gao et al.
RSC ADVANCES (2017)
Discovery of Small Molecules that Induce the Degradation of Huntingtin
Shusuke Tomoshige et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Polycyclic aromatic hydrocarbons. A review
Abdulazeez T. Lawal
COGENT ENVIRONMENTAL SCIENCE (2017)
The endoplasmic reticulum: structure, function and response to cellular signaling
Dianne S. Schwarz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Boc3Arg-Linked Ligands Induce Degradation by Localizing Target Proteins to the 20S Proteasome
Yuntao Shi et al.
ACS CHEMICAL BIOLOGY (2016)
Small-Molecule PROTACS: New Approaches to Protein Degradation
Momar Toure et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Hydrophobic Tagged Dihydrofolate Reductase for Creating Misfolded Glycoprotein Mimetics
Masakazu Hachisu et al.
CHEMBIOCHEM (2016)
The Role of the PERK/eIF2 alpha/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress
W. Rozpedek et al.
CURRENT MOLECULAR MEDICINE (2016)
Structure-Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors
Xiaobao Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The increasing complexity of the ubiquitin code
Richard Yau et al.
NATURE CELL BIOLOGY (2016)
Protein 2B of Coxsackievirus B3 Induces Autophagy Relying on Its Transmembrane Hydrophobic Sequences
Heng Wu et al.
VIRUSES-BASEL (2016)
Identification of pyrazolopyridazinones as PDEd inhibitors
Bjoern Papke et al.
NATURE COMMUNICATIONS (2016)
Induction and inhibition of human cytochrome P4501 by oxygenated polycyclic aromatic hydrocarbons
Emma Wincent et al.
TOXICOLOGY RESEARCH (2016)
Optimized Plk1 PBD Inhibitors Based on Poloxin Induce Mitotic Arrest and Apoptosis in Tumor Cells
Andrej Scharow et al.
ACS CHEMICAL BIOLOGY (2015)
Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging
Jeffrey L. Gustafson et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Development of small molecules targeting the pseudokinase Her3
Sang Min Lim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
The Aryl Hydrocarbon Receptor in Barrier Organ Physiology, Immunology, and Toxicology
Charlotte Esser et al.
PHARMACOLOGICAL REVIEWS (2015)
The First CNS-Active Carborane: A Novel P2X7 Receptor Antagonist with Antidepressant Activity
Shane M. Wilkinson et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Magnetic Norbornene Polymer as Multiresponsive Nanocarrier for Site Specific Cancer Therapy
Vijayakameswara N. Rao et al.
BIOCONJUGATE CHEMISTRY (2014)
Design and synthesis of nonsteroidal progesterone receptor antagonists based on C,C′-diphenylcarborane scaffold as a hydrophobic pharmacophore
Shinya Fujii et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
ER-associated degradation: Protein quality control and beyond
Annamaria Ruggiano et al.
JOURNAL OF CELL BIOLOGY (2014)
Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection
John O. Link et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Pharmacological targeting of the pseudokinase Her3
Ting Xie et al.
NATURE CHEMICAL BIOLOGY (2014)
Targeted protein destabilization reveals an estrogen-mediated ER stress response
Kanak Raina et al.
NATURE CHEMICAL BIOLOGY (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Iain A. Murray et al.
NATURE REVIEWS CANCER (2014)
Progesterone regulates the expression and activity of two mouse isoforms of the glycoprotein folding sensor UDP-Glc: Glycoprotein glucosyltransferase (UGGT)
Maria B. Prados et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives
Lukas Wanka et al.
CHEMICAL REVIEWS (2013)
High Lipophilicity and High Daily Dose of Oral Medications Are Associated With Significant Risk for Drug-Induced Liver Injury
Minjun Chen et al.
HEPATOLOGY (2013)
The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression
Wafa B'chir et al.
NUCLEIC ACIDS RESEARCH (2013)
Artemether-Lumefantrine: An Option for Malaria
Kayla R. Stover et al.
ANNALS OF PHARMACOTHERAPY (2012)
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai et al.
CANCER RESEARCH (2012)
Identification of Hydrophobic Tags for the Degradation of Stabilized Proteins
Hyun Seop Tae et al.
CHEMBIOCHEM (2012)
Inhibitor Mediated Protein Degradation
Marcus J. C. Long et al.
CHEMISTRY & BIOLOGY (2012)
CRABP-II- and FABP5-independent all-trans retinoic acid resistance in COLO 16 human cutaneous squamous cancer cells
Nan-Nan Chen et al.
EXPERIMENTAL DERMATOLOGY (2012)
The influence of lipophilicity in drug discovery and design
John A. Arnott et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
A. Lopez-Girona et al.
LEUKEMIA (2012)
CHEMICAL BIOLOGY Greasy tags for protein removal
Taavi K. Neklesa et al.
NATURE (2012)
Complete subunit architecture of the proteasome regulatory particle
Gabriel C. Lander et al.
NATURE (2012)
The unfolded protein response: controlling cell fate decisions under ER stress and beyond
Claudio Hetz
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Inducible, reversible system for the rapid and complete degradation of proteins in mammalian cells
Andrew J. Holland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Delineation of the Core Aggregation Sequences of TDP-43 C-Terminal Fragment
Akash Saini et al.
CHEMBIOCHEM (2011)
Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies
Matthias Scholz et al.
CHEMICAL REVIEWS (2011)
Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds
Fatiah Issa et al.
CHEMICAL REVIEWS (2011)
Boron Cluster-based Development of Potent Nonsecosteroidal Vitamin D Receptor Ligands: Direct Observation of Hydrophobic Interaction between Protein Surface and Carborane
Shinya Fujii et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Exposed hydrophobicity is a key determinant of nuclear quality control degradation
Eric K. Fredrickson et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Pyrene: A Probe to Study Protein Conformation and Conformational Changes
Gursharan Bains et al.
MOLECULES (2011)
Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins
Taavi K. Neklesa et al.
NATURE CHEMICAL BIOLOGY (2011)
TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies
Todd J. Cohen et al.
TRENDS IN MOLECULAR MEDICINE (2011)
β-Naphthoflavone analogs as potent and soluble aryl hydrocarbon receptor agonists: Improvement of solubility by disruption of molecular planarity
Yuji Fujita et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Discovery of Carboranes as Inducers of 20S Proteasome Activity
Hyun Seung Ban et al.
CHEMMEDCHEM (2010)
NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets
Vladimir Kirkin et al.
AUTOPHAGY (2009)
SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples
Andrew Conroy et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Quality Control Against Misfolded Proteins in the Cytosol: A Network for Cell Survival
Hiroshi Kubota
JOURNAL OF BIOCHEMISTRY (2009)
Fluorene-Based Materials and Their Supramolecular Properties
Robert Abbel et al.
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY (2009)
Hydrophobic statins induce autophagy in cultured human rhabdomyosarcoma cells
Makoto Araki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
Ashley R. Schneekloth et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Structural basis for the function and inhibition of an influenza virus proton channel (vol 451, pg 596, 2008)
Amanda L. Stouffer et al.
NATURE (2008)
The menthol receptor TRPM8 is the principal detector of environmental cold
Diana M. Bautista et al.
NATURE (2007)
Dioxin receptor is a ligand-dependent E3 ubiquitin ligase
Fumiaki Ohtake et al.
NATURE (2007)
A quantitative assessment of hERG liability as a function of lipophilicity
Michael J. Waring et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Boron units as pharmacophores - New applications and opportunities of boron cluster chemistry
Zbigniew J. Lesnikowski
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS (2007)
Protein-misfolding diseases and chaperone-based therapeutic approaches
TK Chaudhuri et al.
FEBS JOURNAL (2006)
Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography
CH Yoon et al.
JOURNAL OF BIOMOLECULAR SCREENING (2006)
Synthesis and biological activity of isoxazolidinyl polycyclic aromatic hydrocarbons: Potential DNA intercalators
A Rescifina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Carcinogenicity of polycyclic aromatic hydrocarbons
K Straif et al.
LANCET ONCOLOGY (2005)
Polycyclic aromatic hydrocarbons and fatal ischemic heart disease
I Burstyn et al.
EPIDEMIOLOGY (2005)
A possible mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons
S Iwano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
A new class of androgen receptor antagonists bearing carborane in place of a steroidal skeleton
S Fujii et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Synthetic substrates for an endoplasmic reticulum protein-folding sensor, UDP-glucose: Glycoprotein glucosyltransferase
K Totani et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1
NN Iwakoshi et al.
NATURE IMMUNOLOGY (2003)
Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and TAT: A kinetic and efficacy study
YL Tseng et al.
MOLECULAR PHARMACOLOGY (2002)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)